Orthopedic Design & Technology Forum in Memphis Tennessee – May 3, 2012

CirQuest Labs, LLC will be attending the upcoming ODT Forum in Memphis Tennessee on May 3, 2012. As an industry leader in life science services, CirQuest will promote validation testing capabilities and will network with industry professionals.The focus of this year’s ODT Forum is to encourage and facilitate the orthopedic manufacturing industries working together with the collective goal of technical and operational excellence in the orthopedic industry.

Lisa Jennings Among Those Honored as 2012 Women of Achievement

Women of Achievement, Inc. was founded in 1984 by a group of women dedicated to honoring the extraordinary women who have made Memphis and Shelby County better through their lives and accomplishments. The coalition of diverse civic and professional groups and support agencies organizes events to recognize and celebrate these women.

The significance of CirQuest Labs and Memphis’ bioscience community

Dr. Lisa Jennings understands that creating new drugs is important. She also understands that how the drug interacts with the body is even more important. Jennings is the founder of CirQuest Labs, a three-year-old contract research organization (CRO) that provides an array of support services to pharmaceutical companies as well as academic institutions that carry out translational and clinical research. CirQuest Labs, which partners with Innova, is run out of the Memphis Bioworks Foundation.

Download the full article (.doc)

Memphis has history of entrepreneurship

As we read words and phrases like “innovation,” “imagination,” “think big,” “turn ideas into reality” and “make their mark,” it is hard to imagine a community that serves as a better example of that spirit than Memphis. If you have read the newspaper over the last few weeks, you have seen story after story suggesting that Memphis is on the precipice of making some very important impacts on the worlds of bioscience and health. There has been coverage of companies coming to market, of research progressing out of the lab, of dollars flowing into our community and of jobs being created….

…CirQuest Labs is an innovative drug-development services company that evolved from more than 20 years of laboratory experience and now offers a range of preclinical and clinical development services to companies worldwide.

Download the full article (.doc)

Physician Spotlight : David Jennings, MD

Internist David Jennings, MD, never knew any doctors growing up, but his college job as an orderly gave him the insight he needed to confirm a simple fact: he wanted to become one. As an orderly, he did menial jobs at the hospital in Knoxville where he worked, bathing patients, listening to their worries, answering simple questions and providing care during a difficult time. But the work held meaning for him, as well as those he served.

Download the full article (.pdf)

Memphis Business Journal – 07/01/2011

After initial success performing research and drug trials for large pharmaceutical manufacturers, a young Memphis biotech firm is ready to swing for the fences.

CirQuest Labs is preparing to begin research and de- velopment into its own anti-clotting drugs.

CirQuest hopes to receive a $450,000 Small Business Innovation Research Grant in March from the U.S. Small Business Administration’s Office of Technology. If its initial research efforts show promise, CirQuest could qualify for a second grant worth up to $1.

Continue reading

Dr. Lisa Jennings leverages strength of Memphis bioscience ecosystem

Ask Dr. Lisa Jennings, director of vascular biology at the University of Tennessee Health Science Center and founder of CirQuest Labs, about the role of academic science in the creation of future jobs and her answer is clear: “I’m a firm believer that it’s the science that drives the development of a product or a device.” Jennings’ talented team offers drug- and device-development services that leverage her considerable experience in navigating the product-development process. Specifically, they guide researchers and pharmaceutical companies through the rigorous preclinical and clinical phases of clinical trials on the road to successful commercialization.

Download the full article (.pdf)